Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey M Munger

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Oncology|May 11, 2006
Dendritic cell-based therapy for mantle cell lymphomaCorey M Munger, Julie M Vose, Shantaram S Joshi
Breast Cancer Research and Treatment|March 6, 2004
Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivoPeng Wang, Corey M Munger, Avadhut D Joshi, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2012
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphomaCorey M Munger, Ganapati V Hegde, Dennis D Weisenburger, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cellsAvadhut D Joshi, Erin M Clark, Peng Wang, et al.
Molecular Cancer Therapeutics|June 6, 2008
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphomaGanapati V Hegde, Corey M Munger, Katy Emanuel, et al.
International Journal of Cancer|April 19, 2012
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signalingGanapati V Hegde, Tara M Nordgren, Corey M Munger, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Oncology|May 11, 2006
Dendritic cell-based therapy for mantle cell lymphomaCorey M Munger, Julie M Vose, Shantaram S Joshi
Breast Cancer Research and Treatment|March 6, 2004
Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivoPeng Wang, Corey M Munger, Avadhut D Joshi, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2012
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphomaCorey M Munger, Ganapati V Hegde, Dennis D Weisenburger, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cellsAvadhut D Joshi, Erin M Clark, Peng Wang, et al.
Molecular Cancer Therapeutics|June 6, 2008
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphomaGanapati V Hegde, Corey M Munger, Katy Emanuel, et al.
International Journal of Cancer|April 19, 2012
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signalingGanapati V Hegde, Tara M Nordgren, Corey M Munger, et al.
Pageof 1